New insights into DNA-binding by type IIA topoisomerases

Current Opinion in Structural Biology

Volumn 23, Issue 1, 2013, Pages 125-133

  Chang, Chih Chiang ^a   Wang, Ying Ren ^a   Chen, Shin Fu ^a   Wu, Chyuan Chuan ^a   Chan, Nei Li ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE; ISOLEUCINE; MITOXANTRONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AMINO TERMINAL SEQUENCE; BASE PAIRING; CARBOXY TERMINAL SEQUENCE; CATALYSIS; COMPLEX FORMATION; DNA BINDING; DNA SUPERCOILING; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVITY; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CLEAVAGE; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN MOTIF; REVIEW; RNA STRUCTURE; STAPHYLOCOCCUS AUREUS;

CONSERVED SEQUENCE; DNA; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; HUMANS; ISOLEUCINE; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS;

EID: 84873523143     PISSN: 0959440X     EISSN: 1879033X     Source Type: Journal    
DOI: 10.1016/j.sbi.2012.11.011     Document Type: Review

References (53)

1. Wang J.C. Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol 2002, 3:430-440.
2. Schoeffler A.J., Berger J.M. DNA topoisomerases: harnessing and constraining energy to govern chromosome topology. Q Rev Biophys 2008, 41:41-101.
3. Vos S.M., Tretter E.M., Schmidt B.H., Berger J.M. All tangled up: how cells direct, manage and exploit topoisomerase function. Nat Rev Mol Cell Biol 2011, 12:827-841.
4. Champoux J.J. DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem 2001, 70:369-413.
5. Liu Q., Wang J.C. Similarity in the catalysis of DNA breakage and rejoining by type IA and IIA DNA topoisomerases. Proc Natl Acad Sci USA 1999, 96:881-886.
6. Roca J., Wang J.C. The capture of a DNA double helix by an ATP-dependent protein clamp: a key step in DNA transport by type II DNA topoisomerases. Cell 1992, 71:833-840.
7. Baird C.L., Harkins T.T., Morris S.K., Lindsley J.E. Topoisomerase II drives DNA transport by hydrolyzing one ATP. Proc Natl Acad Sci USA 1999, 96:13685-13690.
8. Roca J., Berger J.M., Harrison S.C., Wang J.C. DNA transport by a type II topoisomerase: direct evidence for a two-gate mechanism. Proc Natl Acad Sci USA 1996, 93:4057-4062.
9. Dong K.C., Berger J.M. Structural basis for gate-DNA recognition and bending by type IIA topoisomerases. Nature 2007, 450:1201-1205.
10. Schmidt B.H., Burgin A.B., Deweese J.E., Osheroff N., Berger J.M. A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases. Nature 2010, 465:641-644.
11. Bax B.D., Chan P.F., Eggleston D.S., Fosberry A., Gentry D.R., Gorrec F., Giordano I., Hann M.M., Hennessy A., Hibbs M., et al. Type IIA. topoisomerase inhibition by a new class of antibacterial agents. Nature 2010, 466:935-940.
12. Wohlkonig A., Chan P.F., Fosberry A.P., Homes P., Huang J., Kranz M., Leydon V.R., Miles T.J., Pearson N.D., Perera R.L., et al. Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance. Nat Struct Mol Biol 2010, 17:1152-1153.
13. Wu C.C., Li T.K., Farh L., Lin L.Y., Lin T.S., Yu Y.J., Yen T.J., Chiang C.W., Chan N.L. Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide. Science 2011, 333:459-462.
14. Wendorff T.J., Schmidt B.H., Heslop P., Austin C.A., Berger J.M. The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage. J Mol Biol 2012, 424:109-124.
15. Laponogov I., Pan X.S., Veselkov D.A., McAuley K.E., Fisher L.M., Sanderson M.R. Structural basis of gate-DNA breakage and resealing by type II topoisomerases. PLoS ONE 2010, 5:e11338.
16. Laponogov I., Sohi M.K., Veselkov D.A., Pan X.S., Sawhney R., Thompson A.W., McAuley K.E., Fisher L.M., Sanderson M.R. Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases. Nat Struct Mol Biol 2009, 16:667-669.
17. Berger J.M., Gamblin S.J., Harrison S.C., Wang J.C. Structure and mechanism of DNA topoisomerase II. Nature 1996, 379:225-232.
18. Morais Cabral J.H., Jackson A.P., Smith C.V., Shikotra N., Maxwell A., Liddington R.C. Crystal structure of the breakage-reunion domain of DNA gyrase. Nature 1997, 388:903-906.
19. Obsil T., Obsilova V. Structural basis for DNA recognition by FOXO proteins. Biochim Biophys Acta 2011, 1813:1946-1953.
20. Gajiwala K.S., Burley S.K. Winged helix proteins. Curr Opin Struct Biol 2000, 10:110-116.
21. Berger J.M., Fass D., Wang J.C., Harrison S.C. Structural similarities between topoisomerases that cleave one or both DNA strands. Proc Natl Acad Sci USA 1998, 95:7876-7881.
22. Zhang Z., Cheng B., Tse-Dinh Y.C. Crystal structure of a covalent intermediate in DNA cleavage and rejoining by Escherichia coli DNA topoisomerase I. Proc Natl Acad Sci USA 2011, 108:6939-6944.
23. Nichols M.D., DeAngelis K., Keck J.L., Berger J.M. Structure and function of an archaeal topoisomerase VI subunit with homology to the meiotic recombination factor Spo11. EMBO J 1999, 18:6177-6188.
24. Buhler C., Lebbink J.H., Bocs C., Ladenstein R., Forterre P. DNA topoisomerase VI generates ATP-dependent double-strand breaks with two-nucleotide overhangs. J Biol Chem 2001, 276:37215-37222.
25. Wolberger C., Campbell R. New perch for the winged helix. Nat Struct Biol 2000, 7:261-262.
26. Lee S., Jung S.R., Heo K., Byl J.A., Deweese J.E., Osheroff N., Hohng S. DNA cleavage and opening reactions of human topoisomerase IIalpha are regulated via Mg2+-mediated dynamic bending of gate-DNA. Proc Natl Acad Sci USA 2012, 109:2925-2930.
27. Werner M.H., Gronenborn A.M., Clore G.M. Intercalation, DNA kinking, and the control of transcription. Science 1996, 271:778-784.
28. Zhang Z., Gong Y., Guo L., Jiang T., Huang L. Structural insights into the interaction of the crenarchaeal chromatin protein Cren7 with DNA. Mol Microbiol 2010, 76:749-759.
29. Mouw K.W., Rice P.A. Shaping the Borrelia burgdorferi genome: crystal structure and binding properties of the DNA-bending protein Hbb. Mol Microbiol 2007, 63:1319-1330.
30. Swinger K.K., Rice P.A. IHF and HU: flexible architects of bent DNA. Curr Opin Struct Biol 2004, 14:28-35.
31. Fass D., Bogden C.E., Berger J.M. Quaternary changes in topoisomerase II may direct orthogonal movement of two DNA strands. Nat Struct Biol 1999, 6:322-326.
32. Aravind L., Leipe D.D., Koonin E.V. Toprim - a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins. Nucleic Acids Res 1998, 26:4205-4213.
33. Sissi C., Palumbo M. Effects of magnesium and related divalent metal ions in topoisomerase structure and function. Nucleic Acids Res 2009, 37:702-711.
34. Yang W. Topoisomerases and site-specific recombinases: similarities in structure and mechanism. Crit Rev Biochem Mol Biol 2010, 45:520-534.
35. Wasserman R.A., Wang J.C. Analysis of yeast DNA topoisomerase II mutants resistant to the antitumor drug amsacrine. Cancer Res 1994, 54:1795-1800.
36. Rymer R.U., Solorio F.A., Tehranchi A.K., Chu C., Corn J.E., Keck J.L., Wang J.D., Berger J.M. Binding mechanism of MetalNTP substrates and stringent-response alarmones to bacterial DnaG-type primases. Structure 2012, 20:1478-1489.
37. Rodina A., Godson G.N. Role of conserved amino acids in the catalytic activity of Escherichia coli primase. J Bacteriol 2006, 188:3614-3621.
38. Nitiss J.L. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer 2009, 9:338-350.
39. Deweese J.E., Osheroff N. The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing. Nucleic Acids Res 2009, 37:738-748.
40. Pommier Y., Marchand C. Interfacial inhibitors: targeting macromolecular complexes. Nat Rev Drug Discov 2012, 11:25-36.
41. Spitzner J.R., Muller M.T. A consensus sequence for cleavage by vertebrate DNA topoisomerase II. Nucleic Acids Res 1988, 16:5533-5556.
42. Capranico G., De Isabella P., Tinelli S., Bigioni M., Zunino F. Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II. Biochemistry 1993, 32:3038-3046.
43. Capranico G., Tinelli S., Zunino F., Kohn K.W., Pommier Y. Effects of base mutations on topoisomerase II DNA cleavage stimulated by mAMSA in short DNA oligomers. Biochemistry 1993, 32:145-152.
44. Leo E., Gould K.A., Pan X.S., Capranico G., Sanderson M.R., Palumbo M., Fisher L.M. Novel symmetric and asymmetric DNA scission determinants for Streptococcus pneumoniae topoisomerase IV and gyrase are clustered at the DNA breakage site. J Biol Chem 2005, 280:14252-14263.
45. Drlica K., Hiasa H., Kerns R., Malik M., Mustaev A., Zhao X. Quinolones: action and resistance updated. Curr Top Med Chem 2009, 9:981-998.
46. Vassetzky Y.S., Alghisi G.C., Gasser S.M. DNA topoisomerase II mutations and resistance to anti-tumor drugs. Bioessays 1995, 17:767-774.
47. Liu L.F. DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 1989, 58:351-375.
48. Azarova A.M., Lyu Y.L., Lin C.P., Tsai Y.C., Lau J.Y., Wang J.C., Liu L.F. Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. Proc Natl Acad Sci USA 2007, 104:11014-11019.
49. Gubaev A., Klostermeier D. DNA-induced narrowing of the gyrase N-gate coordinates T-segment capture and strand passage. Proc Natl Acad Sci USA 2011, 108:14085-14090.
50. Hardin A.H., Sarkar S.K., Seol Y., Liou G.F., Osheroff N., Neuman K.C. Direct measurement of DNA bending by type IIA topoisomerases: implications for non-equilibrium topology simplification. Nucleic Acids Res 2011, 39:5729-5743.
51. Corbett K.D., Shultzaberger R.K., Berger J.M. The C-terminal domain of DNA gyrase A adopts a DNA-bending beta-pinwheel fold. Proc Natl Acad Sci USA 2004, 101:7293-7298.
52. Kampranis S.C., Maxwell A. Conversion of DNA gyrase into a conventional type II topoisomerase. Proc Natl Acad Sci USA 1996, 93:14416-14421.
53. Schmidt B.H., Osheroff N., Berger J.M. Structure of a topoisomerase II-DNA-nucleotide complex reveals a new control mechanism for ATPase activity. Nat Struct Mol Biol 2012, 19:1147-1154.